MIM
SGRX

Macroview Investment Management’s SANGRIX INC. Class A Ordinary Shares SGRX Stock Holding History

Macroview Investment Management’s Portfolio SGRX Stock Details SGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-38
Closed -$4.4K – 99
2025
Q3 		$4.4K Buy
+38
New +$4.71K ﹤0.01% 93

Other funds holding SGRX

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
XSC
X-Square Capital Guaynabo, Puerto Rico $394M AUM 44.75% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

Macroview Investment Management's SGRX Position: Q4 2025 in Review

Macroview Investment Management sold out of SANGRIX INC. Class A Ordinary Shares (SGRX) in Q4 2025, closing a stake of 38 shares — an estimated $4.4K sold.

Macroview Investment Management first reported a position in SGRX in Q3 2025 and held it in 1 quarter. The position peaked at $4.4K in Q3 2025. 13 funds tracked by Wall St. Rank hold SGRX as of Q4 2025.

  • Macroview Investment Management reported no remaining SANGRIX INC. Class A Ordinary Shares position as of Q4 2025 after selling out during the quarter.
  • Macroview Investment Management sold 38 SANGRIX INC. Class A Ordinary Shares shares in Q4 2025, an estimated $4.4K.
  • Macroview Investment Management first reported a position in SANGRIX INC. Class A Ordinary Shares in Q3 2025 and held it in 1 quarter.
  • Macroview Investment Management's SANGRIX INC. Class A Ordinary Shares position peaked at $4.4K in Q3 2025.
  • 13 funds tracked by Wall St. Rank held SANGRIX INC. Class A Ordinary Shares as of Q4 2025.

Based on Macroview Investment Management's 13F filing for Q4 2025, filed 5 Feb 2026.